ArticleBiomedicines2024

Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort.

Agnese Colpani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.